Forte Biosciences annual operating margin
2016
2017
2018
2019
Forte Biosciences Operating Margin Growth & History (FBRX)
Forte Biosciences's operating margin was −11,288.89% for fiscal 2019.
View full Forte Biosciences company overviewForte Biosciences annual operating margin history
| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2019 | 2019-12-31 | −11,288.89% | −11034.66 pp |
| 2018 | 2018-12-31 | −254.23% | +91521.38 pp |
| 2017 | 2017-12-31 | −91,775.61% | −27102.14 pp |
| 2016 | 2016-12-31 | −64,673.47% | — |
Forte Biosciences quarterly operating margin
Q2.17
Q3.17
Q1.18
Q2.18
Q3.18
Q4.18
Q1.19
Q2.19
Q3.19
Q4.19
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q4 2019 | 2019-12-31 | 156,888.89% | +369188.89 pp |
| Q3 2019 | 2019-09-30 | −7,600.00% | −7607.92 pp |
| Q2 2019 | 2019-06-30 | −6,988.89% | +163311.11 pp |
| Q1 2019 | 2019-03-31 | −187,455.56% | −44722.22 pp |
| Q4 2018 | 2018-12-31 | −212,300.00% | −114930.00 pp |
| Q3 2018 | 2018-09-30 | 7.92% | +86527.92 pp |
| Q2 2018 | 2018-06-30 | −170,300.00% | — |
| Q1 2018 | 2018-03-31 | −142,733.33% | — |
| Q3 2017 | 2017-09-30 | −97,370.00% | — |
| Q2 2017 | 2017-06-30 | −86,520.00% | — |
Forte Biosciences operating margin trends
Across the available reported history, Forte Biosciences's operating margin decreased from −254.23% to −11,288.89%, a change of −11034.66 percentage points. The latest reported quarter, Q4 2019, shows 156,888.89%.
About the metric
What operating margin means
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
Calculation and source
How operating margin is calculated
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Forte Biosciences filings at SEC.gov ↗